Related Experiment Video
Updated: Jan 24, 2026

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
Published on: November 13, 2012
Developing Picornaviruses for Cancer Therapy
Cormac McCarthy1, Nadishka Jayawardena2, Laura N Burga3
1Department of Microbiology and Immunology, University of Otago, Dunedin 9016, New Zealand. mccco791@student.otago.ac.nz.
Abstract:
Oncolytic viruses (OVs) form a group of novel anticancer therapeutic agents which selectively infect and lyse cancer cells. Members of several viral families, including Picornaviridae, have been shown to have anticancer activity. Picornaviruses are small icosahedral non-enveloped, positive-sense, single-stranded RNA viruses infecting a wide range of hosts. They possess several advantages for development for cancer therapy: Their genomes do not integrate into host chromosomes, do not encode oncogenes, and are easily manipulated as cDNA. This review focuses on the picornaviruses investigated for anticancer potential and the mechanisms that underpin this specificity.
Insights
Picornaviruses are being explored as novel anticancer agents. These oncolytic viruses (OVs) selectively target and destroy cancer cells, offering a promising therapeutic approach.
Area of Science:
- Virology
- Oncology
- Gene Therapy
Background:
- Oncolytic viruses (OVs) represent a novel class of anticancer therapeutics.
- Several viral families, including Picornaviridae, exhibit anticancer properties.
- Picornaviruses are small, non-enveloped RNA viruses with potential for cancer treatment.
Purpose of the Study:
- To review picornaviruses investigated for their anticancer potential.
- To elucidate the mechanisms underlying the cancer-specific activity of picornaviruses.
Main Methods:
- Literature review of studies on picornaviruses as anticancer agents.
- Analysis of viral characteristics relevant to cancer therapy.
- Examination of mechanisms of viral oncolysis and tumor specificity.
Main Results:
- Picornaviruses demonstrate selective infection and lysis of cancer cells.
- Advantages for cancer therapy include non-integration of genomes, absence of oncogenes, and ease of genetic manipulation.
- Specific picornaviruses have been identified and studied for their therapeutic efficacy.
Conclusions:
- Picornaviruses hold significant promise as oncolytic viruses for cancer treatment.
- Their inherent biological properties contribute to their specificity and safety profile.
- Further research into picornavirus mechanisms can optimize their use in oncology.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Gene Therapy
Group Therapy
Psychodynamic Therapy
Humanistic Therapy

